Jul 8, 2010

[MedicalConspiracies] Mylotarg is DEADLY to Cancer Patients! (It seems that the medical community is trying to KILL us!)

It seems that the medical community is trying to KILL us!

 

 

HSI eAlert



You have received this e-mail because our records indicate that you signed up for a free subscription to the HSI eAlert eLetter.


 


Dear Reader,

How do you completely botch the approval of a cancer drug and put thousands of desperate patients at increased risk of death while wasting their money?

The FDA and Wyeth have kindly given us a master class in All the Wrong Moves.

First you develop a drug that promises to be a genuine lifesaver. That was the hype, anyway, back in 2000 when Wyeth asked the FDA to give accelerated approval to Mylotarg.

You've probably never heard of Mylotarg because its use is so specific. It's designed to treat a relatively rare type of blood cancer called acute myeloid leukemia (AML), which occurs mostly in people over the age of 60.

Early tests suggested that Mylotarg use might improve remission rate, and increase overall survival by a few months.

So the FDA gave the drug accelerated approval, but only for patients who had suffered a first relapse of AML and weren't eligible for other chemotherapies. And as with any drug approved on the fast-track program, Wyeth was required to mount further research.

And this is where things started to go off the rails.

It took Wyeth four years to begin the follow-up Mylotarg study. Four deadly years.

-----------------------------------------------------------
Fast forward...
-----------------------------------------------------------

Wyeth is no more. They were purchased by Pfizer in 2009. But the Mylotarg study they started years ago continued.

Until last month.

One full decade after Mylotarg's hasty approval, Pfizer abruptly stopped the study and took the drug off the market for two reasons: 1) Mylotarg use showed no benefit, and 2) Compared to patients who used standard therapy, it appeared that patients who used standard therapy plus Mylotarg were FOUR TIMES more likely to die during the study!

Meanwhile, this dangerous, poorly-studied drug made millions for Wyeth and Pfizer.

Business Week reports that the sales of Mylotarg in the first quarter of this year were nearly $9 million. But only about 2,500 patients have been using Mylotarg each year.

Don't reach for your calculator--I've already done the math. Apparently, each patient paid more than $14,000 for the required two injections of a drug that doesn't work and might be fatal.

Now, by Big Pharma standards, $14,000 is nothing. That's just walking around money. That's hardly enough to buyoff a politician.

But for most patients and their families, a $14,000 medical bill is a serious hardship. Nevertheless, you can be sure that many families who trusted the FDA were plunged into debt or raided their life savings to give their loved one every chance to live, based entirely on Mylotarg's status as a promising miracle drug.

Ah well--la de da--file it under "lessons learned," right? As one FDA official told Business Week, follow-up trials for fast-tracked drugs should probably be planned and "if possible" already underway when the application is submitted.

Gee, it seems like that would have been a really obvious detail to address TEN YEARS AGO!


 

Are you one of the 50% of Americans whose arthritis could be caused by a hidden bacterial infection attacking your joints...?

Get the latest and most valuable information on natural supplements that may be able to

  • Reduce inflammation by as much as 97%
  • Block up to 50% of rheumatoid arthritis attacks
  • Cut your swelling in half by sipping a soothing herbal tea
  • Learn if your low-fat diet is literally drying out your joints.
  • Reveal 15 hidden warning signs that your arthritis is getting worse

Discover more ground-breaking news about these safe, natural, and powerful arthritis-busting solutions.

http://clicks.hsibaltimore.com//t/AQ/AAHnZg/AAHuxw/AAID+Q/AQ/Ab63CA/IrF9



...and another thing

If you want to strengthen bones without drug side effects, some HSI members have a suggestion for that...

After I sent you a recent e-mail about the dangers of osteoporosis drugs, I received several messages from readers about strontium, an important mineral that can actually increase retention of calcium.

Nancy: "You absolutely MUST have strontium included in the mix for bone building."

Jan agrees, noting that strontium reversed her osteo problems. Jan: "I took 680 MG per day for 10 months. I now take 340 MG of Strontium Citrate for maintenance. It's important to take strontium & calcium separately, so I take one in the morning & divide the (1000 MG) calcium/magnesium (500 MG) in the evening."

It's almost as if Jan has been reading Dr. Spreen's mind (or maybe one of his books).

Dr. Spreen: "Ward Dean, M.D., reports that studies of the use of strontium show it to be safe in doses up to 1.7 grams/day, though effective supplemental use of the mineral nutrient tends to be optimized at around 680 milligrams, with lower doses also being effective for osteoporosis (and even cavities).

"It should be noted that its absorption is inhibited when combined with calcium, and the mineral is best absorbed when taken on an empty stomach (one of the few nutrients other than amino acids in which that tends to be true).”

Strontium has been proven to increase bone mineral density, with an important additional benefit. In a study from the Mayo clinic, more than 80 percent of osteoporosis patients reported significant pain reduction while using strontium.

To Your Good Health,

Jenny Thompson


 

Introducing the most powerful source of antioxidants ever discovered...

..and until recently, we've been throwing it away!

What has more antioxidant power than a pound of raspberries, a pound and a half of broccoli or four pots of brewed coffee?

Believe it or not, it's been right under our noses, growing in huge tropical fields for hundreds of years.

And until now, we've been throwing it away!

Visit the link below and learn how this powerful nutrient can help you look younger, feel younger and protect you from one of today's biggest health threats.

Don't wait another second...put this natural powerhouse to work for you now!

http://clicks.hsibaltimore.com//t/AQ/AAHnZg/AAHuxw/AAID+g/AQ/Ab63CA/lF3h


To start receiving your own copy of the HSI e-Alert, visit:
http://clicks.hsibaltimore.com//t/AQ/AAHnZg/AAHuxw/C4U/Ag/Ab63CA/SpiW
Or forward this e-mail to a friend so they can sign-up to receive their own copy of the HSI e-Alert.


Sources:
"FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. Market" FDA News Release, 6/21/10, fda.gov
"Pfizer Withdraws Drug After Deaths, No Proven Benefit" Catherine Larkin, Business Week, 6/21/10, businessweek.com

The information in this e-mail is offered as a general guideline, not one-size-fits-all medical advice. Talk to your doctor before making any changes in your personal health care regimen.


Copyright (c)2010 by Healthier News, LLC. Thank you for your interest in the Health Sciences Institute of Baltimore. We do not allow republication of our full newsletters and articles. However, you can post a portion (no more than 90 words, 1-2 paragraphs) of our content with a live link back to our homepage (www.hsibaltimore.com), or a link to the specific article you are quoting from.


Before you hit reply to send us a question or request, please visit here http://clicks.hsibaltimore.com//t/AQ/AAHnZg/AAHuxw/C4c/AQ/Ab63CA/JiBv


Got 60 seconds? Learn how you can receive our complete encyclopedia "HSI's 100 Greatest Underground Cures" absolutely FREE.
http://clicks.hsibaltimore.com//t/AQ/AAHnZg/AAHuxw/AAEtYg/AQ/Ab63CA/4jXl


If you want to end your HSI e-Alert subscription or you need to change your e-mail address, please follow the instructions below. Your changes will be effective immediately. However, if you do not follow the instructions below and simply hit reply instead, we may not receive your request and cannot assure you that it will be completed.



To manage your subscription by mail or for any other subscription issues, write us at:

Order Processing Center
Attn: Customer Service
P.O. Box 925
Frederick, MD 21705 USA

0 comments: